Smith & Nephew plc
SN
Rank in Stocks
#1674
Smith & Nephew plc, along with its subsidiaries, operates globally as a... Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for joint reconstruction. This segment also provides trauma and extremities products, including internal and external fixation devices crucial for stabilizing severe fractures and correcting deformities. In the sports medicine field, the company furnishes surgeons with comprehensive joint repair solutions. These encompass specialized instruments, advanced technologies, and implants necessary for minimally invasive joint surgeries, addressing soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. Additionally, its arthroscopic enabling technologies support surgical visualization and intervention inside joints, comprising fluid management equipment, high-definition cameras, digital image capture systems, scopes, light sources, and monitors. It also supplies radiofrequency, electromechanical, and mechanical tissue resection devices, along with hand instruments for removing damaged tissue, and provides ear, nose, and throat (ENT) solutions. Furthermore, Smith & Nephew delivers sophisticated advanced wound management solutions. This category features products for the treatment and prevention of acute and chronic wounds, including leg, diabetic, and pressure ulcers, burns, and post-operative wounds. Its offerings extend to advanced wound bioactives, incorporating biologics and other active technologies for debridement, dermal repair, and regeneration, as well as regenerative medicine products like skin, bone graft, and articular cartilage substitutes. The advanced wound devices portfolio includes traditional and single-use negative pressure wound therapy systems, alongside hydrosurgery devices. Primarily serving healthcare providers, Smith & Nephew plc was founded in 1856 and maintains its corporate headquarters in Watford, United Kingdom.
Share Price
$15.33
Last synced: 2026-11-09
Market Cap
$12.83B
Change (1 day)
-1.18%
Change (1 year)
-7.89%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Smith & Nephew plc (SN)
Category
Healthcare
Dividend history for Smith & Nephew plc (SN)
Smith & Nephew plc (stock symbol: SN) made a total of 69 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $7.77
Dividend yield (TTM) : 2.66%
The sum of all dividends (adjusted for stock splits) is : $7.77
Dividend yield (TTM) : 2.66%
Dividend payments for Smith & Nephew plc (SN) from 1993 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.4 | 5.38% |
| 2025 | $0.38 | -13.64% |
| 2024 | $0.44 | 17.37% |
| 2023 | $0.37 | -3.49% |
| 2022 | $0.39 | 3.97% |
| 2021 | $0.37 | -0.69% |
| 2020 | $0.37 | 2.70% |
| 2019 | $0.36 | -0.65% |
| 2018 | $0.37 | 21.18% |
| 2017 | $0.3 | -2.83% |
| 2016 | $0.31 | 3.00% |
| 2015 | $0.3 | 8.22% |
| 2014 | $0.28 | 5.28% |
| 2013 | $0.27 | 27.31% |
| 2012 | $0.21 | 26.41% |
| 2011 | $0.16 | 9.53% |
| 2010 | $0.15 | 10.71% |
| 2009 | $0.14 | 10.27% |
| 2008 | $0.12 | 8.68% |
| 2007 | $0.11 | 9.10% |
| 2006 | $0.1 | 5.67% |
| 2005 | $0.0983 | 9.98% |
| 2004 | $0.0894 | 16.09% |
| 2003 | $0.077 | 10.25% |
| 2002 | $0.0699 | 6.56% |
| 2001 | $0.0656 | -90.08% |
| 2000 | $0.66 | 426.36% |
| 1999 | $0.13 | -0.14% |
| 1998 | $0.13 | 1.47% |
| 1997 | $0.12 | 5.71% |
| 1996 | $0.12 | 6.64% |
| 1995 | $0.11 | 7.54% |
| 1994 | $0.1 | 7.01% |
| 1993 | $0.0955 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.4 | 5.38% |
| 2025 | $0.38 | -13.64% |
| 2024 | $0.44 | 17.37% |
| 2023 | $0.37 | -0.88% |
| 2022 | $0.38 | 1.24% |
| 2021 | $0.37 | -0.69% |
| 2020 | $0.37 | 2.70% |
| 2019 | $0.36 | -0.65% |
| 2018 | $0.37 | 21.18% |
| 2017 | $0.3 | -2.83% |
| 2016 | $0.31 | 3.00% |
| 2015 | $0.3 | 8.22% |
| 2014 | $0.28 | 5.28% |
| 2013 | $0.27 | 27.31% |
| 2012 | $0.21 | 26.41% |
| 2011 | $0.16 | 9.53% |
| 2010 | $0.15 | 10.71% |
| 2009 | $0.14 | 10.27% |
| 2008 | $0.12 | 8.68% |
| 2007 | $0.11 | 9.10% |
| 2006 | $0.1 | 5.67% |
| 2005 | $0.0983 | 9.98% |
| 2004 | $0.0894 | 16.09% |
| 2003 | $0.077 | 10.25% |
| 2002 | $0.0699 | 6.56% |
| 2001 | $0.0656 | -89.86% |
| 2000 | $0.65 | 529.82% |
| 1999 | $0.1 | -0.14% |
| 1998 | $0.1 | 1.47% |
| 1997 | $0.1 | 5.71% |
| 1996 | $0.0959 | 6.64% |
| 1995 | $0.0899 | 7.54% |
| 1994 | $0.0836 | 7.01% |
| 1993 | $0.0781 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 176.00% |
US
|
|
| 181.00% |
IE
|
|
| 87.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
US
|
Questions about Smith & Nephew plc's dividend per share
What is Smith & Nephew plc's dividend per share?
Smith & Nephew plc's dividend per share over the last twelve months is $0.40, as of Oct 2026.
What was Smith & Nephew plc's dividend per share in 2025?
In 2025, Smith & Nephew plc's dividend per share was $0.38, 13.64% less than in 2024 ($0.44).
How has Smith & Nephew plc's dividend per share changed since 2020?
From 2020 to 2025, Smith & Nephew plc's dividend per share went from $0.37 to $0.38, an average growth of 0.20% a year.